Nuclear retinoid receptors and the transcription of retinoid-target genes

Gene

Volumn 328, Issue 1-2, 2004, Pages 1-16

  Bastien, Julie ^a   Rochette Egly, Cécile ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

DBD; Degradation; DNA binding domain; Kinases; LBD; Ligand binding domain; Nuclear receptors; Phosphorylation; RA; RAR; RARE; Retinoic acid; Retinoic acid receptor; Retinoid X receptor; Retinoids; RXR; Transcription; Ubiquitin proteasome

Indexed keywords

NUCLEAR RETINOID RECEPTOR RAR; NUCLEAR RETINOID RECEPTOR RXR; PROTEASOME; RETINOID; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG;

CHROMATIN; CHROMATIN STRUCTURE; CONFORMATIONAL TRANSITION; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HUMANS; MODELS, GENETIC; MULTIENZYME COMPLEXES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; RETINOIDS; TRANSCRIPTION, GENETIC; UBIQUITIN;

EID: 1542710344     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2003.12.005     Document Type: Review

References (144)

1. Aalfs J.D., Kingston R.E. What does 'chromatin remodeling' mean? Trends Biochem. Sci. 25:2000;548-555.
2. Adachi S., Okuno M., Matsushima-Nishiwaki R., Takano Y., Kojima S., Friedman S.L., Moriwaki H., Okano Y. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma. Hepatology. 35:2002;332-340.
3. Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C. Hyperphosphorylation of the retinoid X receptor alpha (RXRa) by activated c-Jun N-terminal kinases (JNKs). J. Biol. Chem. 274:1999;18932-18941.
4. Adelman K., Lis J.T. How does Pol II overcome the nucleosome barrier? Mol. Cell. 9:2002;451-452.
5. Altucci L., Gronemeyer H. Nuclear receptors in cell life and death. Trends Endocrinol. Metab. 12:2001;460-468.
6. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev., Cancer. 1:2001;181-193.
7. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:2001;1269-1304.
8. Barnea E., Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J. Biol. Chem. 275:2000;6608-6619.
9. Bastien J., Adam-Stitah S., Riedl T., Egly J.M., Chambon P., Rochette-Egly C. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J. Biol. Chem. 275:2000;21896-21904.
10. Bastien J., Adam-Stitah S., Plassat J.L., Chambon P., Rochette-Egly C. The phosphorylation site located in the A region of RXRa is required for the anti-proliferative effect of retinoic acid and the activation of RA-target genes in F9 cells. J. Biol. Chem. 24:2002;24.
11. Benkoussa M., Brand C., Delmotte M.H., Formstecher P., Lefebvre P. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol. Cell. Biol. 22:2002;4522-4534.
12. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:2002;142-148.
13. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
14. Bommer M., Benecke A., Gronemeyer H., Rochette-Egly C. TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. J. Biol. Chem. 277:2002;37961-37966.
15. Boudjelal M., Wang Z., Voorhees J.J., Fisher G.J. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res. 60:2000;2247-2252.
16. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 375:1995;377-382.
17. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298.
18. Brower C.S., Sato S., Tomomori-Sato C., Kamura T., Pause A., Stearman R., Klausner R.D., Malik S., Lane W.S., Sorokina I., Roeder R.G., Conaway J.W., Conaway R.C. Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10353-10358.
19. Budhu A.S., Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol. 22:2002;2632-2641.
20. Caelles C., Gonzalez-Sancho J.M., Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11:1997;3351-3364.
21. Cao Z., Flanders K.C., Bertolette D., Lyakh L.A., Wurthner J.U., Parks W.T., Letterio J.J., Ruscetti F.W., Roberts A.B. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. Blood. 101:2003;498-507.
22. Chambon P. A decade of molecular biology ot retinoic acid receptors. FASEB J. 10:1996;940-954.
23. Chen J.D. Steroid/nuclear receptor coactivators. Vitam. Horm. 58:2000;391-448.
24. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science. 284:1999;2174-2177.
25. Chen H., Lin R.J., Xie W., Wilpitz D., Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98:1999;675-686.
26. Cheung P., Allis C.D., Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell. 103:2000;263-271.
27. Conaway R.C., Brower C.S., Conaway J.W. Emerging roles of ubiquitin in transcription regulation. Science. 296:2002;1254-1258.
28. Cosma M.P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol. Cell. 10:2002;227-236.
29. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
30. Delmotte M.H., Tahayato A., Formstecher P., Lefebvre P. Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity. J. Biol. Chem. 274:1999;38225-38231.
31. del Rincon S.V., Rousseau C., Samanta R., Miller W.H. Jr. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. Oncogene. 22:2003;3353-3360.
32. Delva L., Bastie J.N., Rochette-Egly C., Kraiba R., Balitrand N., Despouy G., Chambon P., Chomienne C. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol. Cell. Biol. 19:1999;7158-7167.
33. DeMartino G.N., Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274:1999;22123-22126.
34. Depoix C., Delmotte M.H., Formstecher P., Lefebvre P. Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions. A novel mechanism of action for retinoid antagonists. J. Biol. Chem. 276:2001;9452-9459.
35. Despouy G., Bastie J.N., Deshaies S., Balitrand N., Mazharian A., Rochette-Egly C., Chomienne C., Delva L. Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J. Biol. Chem. 278:2003;6355-6362.
36. de The H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 343:1990;177-180.
37. Dilworth F.J., Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene. 20:2001;3047-3054.
38. Dupe V., Davenne M., Brocard J., Dolle P., Mark M., Dierich A., Chambon P., Rijli F.M. In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3′RARE). Development. 124:1997;399-410.
39. Durand B., Saunders M., Leroy P., Leid M., Chambon P. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell. 71:1992;73-85.
40. Easwaran V., Pishvaian M., Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr. Biol. 9:1999;1415-1418.
41. Egea P.F., Rochel N., Birck C., Vachette P., Timmins P.A., Moras D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J. Mol. Biol. 307:2001;557-576.
42. Egly J.M. The 14th datta lecture. TFIIH: from transcription to clinic. FEBS Lett. 498:2001;124-128.
43. Ferdous A., Gonzalez F., Sun L., Kodadek T., Johnston S.A. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell. 7:2001;981-991.
44. Folkers G.E., van der Leede B.J., van der Saag P.T. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain. Mol. Endocrinol. 7:1993;616-627.
45. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20:2000;5041-5047.
46. Fraser R.A., Rossignol M., Heard D.J., Egly J.M., Chambon P. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J. Biol. Chem. 272:1997;7122-7126.
47. Freeman B.C., Yamamoto K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science. 296:2002;2232-2235.
48. Fry C.J., Peterson C.L. Chromatin remodeling enzymes: who's on first? Curr. Biol. 11:2001;R185-R197.
49. Gehin M., Vivat V., Wurtz J.M., Losson R., Chambon P., Moras D., Gronemeyer H. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Chem. Biol. 6:1999;519-529.
50. Germain P., Iyer J., Zechel C., Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415:2002;187-192.
51. Gianni M., Bauer A., Garattini E., Chambon P., Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RARg degradation and transactivation. EMBO J. 21:2002;3760-3769.
52. Gianni M., Kopf E., Bastien J., Oulad-Abdelghani M., Garattini E., Chambon P., Rochette-Egly C. Down-regulation of the phosphatidylinositol 3-Kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2. J. Biol. Chem. 277:2002;24859-24862.
53. Gianni M., Tarrade A., Nigro E.A., Garattini E., Rochette-Egly C. The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. J. Biol. Chem. 278:2003;34458-34466.
54. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
55. Gonzalez F., Delahodde A., Kodadek T., Johnston S.A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science. 296:2002;548-550.
56. Hittelman A.B., Burakov D., Iniguez-Lluhi J.A., Freedman L.P., Garabedian M.J. Differential regulation of glucocorticoid receptor trancriptional activation via AF-1 associated proteins. EMBO J. 18:1999;5380-5388.
57. Hong S.H., Privalsky M.L. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell. Biol. 20:2000;6612-6625.
58. Imhof M.O., McDonnell D.P. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol. Cell. Biol. 16:1996;2594-2605.
59. Jeanmougin F., Wurtz J.M., Le Douarin B., Chambon P., Losson R. The bromodomain revisited. (letter) Trends Biochem. Sci. 22:1997;151-153.
60. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
61. Kang Z., Pirskanen A., Janne O.A., Palvimo J.J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277:2002;48366-48371.
62. Kastner P., Mark M., Ghyselinck N., Krezel W., Dupe V., Grondona J.M., Chambon P. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development. 124:1997;313-326.
63. Keriel A., Stary A., Sarasin A., Rochette-Egly C., Egly J.M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 109:2002;125-135.
64. Khorasanizadeh S., Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26:2001;384-390.
65. Kingston R.E., Narlikar G.J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13:1999;2339-2352.
66. Klaholz B.P., Renaud J.P., Mitschler A., Zusi C., Chambon P., Gronemeyer H., Moras D. Conformational adaptation of agonists to the human nuclear receptor RAR gamma. Nat. Struct. Biol. 5:1998;199-202.
67. Kopf E., Plassat J.L., Vivat V., de The H., Chambon P., Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 275:2000;33280-33288.
68. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:2000;1176-1179.
69. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:2002;198-209.
70. Laudet V., Gronemeyer H. Nuclear Receptor Factsbook. 2001;Academic Press, London.
71. Lavigne A.C., Mengus G., Gangloff Y.G., Wurtz J.M., Davidson I. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol. Cell. Biol. 19:1999;5486-5494.
72. Lee M.S., Kliewer S.A., Provencal J., Wright P.E., Evans R.M. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science. 260:1993;1117-1121.
73. Lee H.Y., Sueoka N., Hong W.K., Mangelsdorf D.J., Claret F.X., Kurie J.M. All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Mol. Cell. Biol. 19:1999;1973-1980.
74. Lee H.Y., Suh Y.A., Robinson M.J., Clifford J.L., Hong W.K., Woodgett J.R., Cobb M.H., Mangelsdorf D.J., Kurie J.M. Stress pathway activation induces phosphorylation of retinoid X receptor. J. Biol. Chem. 275:2000;32193-32199.
75. Leid M., Kastner P., Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17:1992;427-433.
76. Lin H.K., Altuwaijri S., Lin W.J., Kan P.Y., Collins L.L., Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277:2002;36570-36576.
77. Lo W.S., Duggan L., Tolga N.C., Belotserkovskya R., Lane W.S., Shiekhattar R., Berger S.L. Snf1 - a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription. Science. 293:2001;1142-1146.
78. Lopez G.N., Turck C.W., Schaufele F., Stallcup M.R., Kushner P.J. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276:2001;22177-22182.
79. Loudig O., Babichuk C., White J., Abu-Abed S., Mueller C., Petkovich M. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol. Endocrinol. 14:2000;1483-1497.
80. Malik S., Roeder R.G. Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. Trends Biochem. Sci. 25:2000;277-283.
81. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
82. Mangelsdorf D.J., Umesono K., Kliewer S.A., Borgmeyer U., Ong E.S., Evans R.M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell. 66:1991;555-561.
83. Mark M., Ghyselinck N.B., Wendling O., Dupe V., Mascrez B., Kastner P., Chambon P. A genetic dissection of the retinoid signalling pathway in the mouse. Proc. Nutr. Soc. 58:1999;609-613.
84. Matsushima-Nishiwaki R., Okuno M., Adachi S., Sano T., Akita K., Moriwaki H., Friedman S.L., Kojima S. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res. 61:2001;7675-7682.
85. May M., Mengus G., Lavigne A.C., Chambon P., Davidson I. Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J. 15:1996;3093-3104.
86. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 108:2002;465-474.
87. McKenna N.J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11697-11702.
88. Metivier R., Stark A., Flouriot G., Hubner M.R., Brand H., Penot G., Manu D., Denger S., Reid G., Kos M., Russell R.B., Kah O., Pakdel F., Gannon F. A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell. 10:2002;1019-1032.
89. Montano M.M., Muller V., Trobaugh A., Katzenellenbogen B.S. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol. 9:1995;814-825.
90. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10:1998;384-391.
91. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
92. Muratani M., Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev., Mol. Cell Biol. 4:2003;192-201.
93. Nagpal S., Saunders M., Kastner P., Durand B., Nakshatri H., Chambon P. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell. 70:1992;1007-1019.
94. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., Krishna V., Chatterjee K., Evans R.M., Schwabe J.W.R. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:1999;3209-3216.
95. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 108:2002;475-487.
96. Orphanides G., Reinberg D. RNA polymerase II elongation through chromatin. Nature. 407:2000;471-475.
97. Orphanides G., Reinberg D. A unified theory of gene expression. Cell. 108:2002;439-451.
98. Orphanides G., Lagrange T., Reinberg D. The general transcription factors of RNA polymerase II. Genes Dev. 10:1996;2657-2683.
99. Osburn D.L., Shao G., Seidel H.M., Schulman I.G. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol. Cell. Biol. 21:2001;4909-4918.
100. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:2001;153-183.
101. Pendaries V., Verrecchia F., Michel S., Mauviel A. Retinoic acid receptors interfere with the TGF-b/Smad signaling pathway in a ligand-specific manner. Oncogene. 22:2003;8212-8220.
102. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones R., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:1999;3198-3208.
103. Picard E., Seguin C., Monhoven N., Rochette-Egly C., Siat J., Borrelly J., Martinet Y., Martinet N., Vignaud J.M. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. (see comments) J. Natl. Cancer Inst. 91:1999;1059-1066.
104. Qian A., Cai Y., Magee T.R., Wan Y.J. Identification of retinoic acid-responsive elements on the HNF1alpha and HNF4alpha genes. Biochem. Biophys. Res. Commun. 276:2000;837-842.
105. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struck. Biol. 11:2001;33-38.
106. Rastinejad F., Wagner T., Zhao Q., Khorasanizadeh S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J. 19:2000;1045-1054.
107. Reid G., Hubner M.R., Metivier R., Brand H., Denger S., Manu D., Beaudouin J., Ellenberg J., Gannon F. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell. 11:2003;695-707.
108. Renaud J.P., Moras D. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57:2000;1748-1769.
109. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
110. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal. 15:2003;355-366.
111. Rochette-Egly C., Chambon P. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Histol. Histopathol. 16:2001;909-922.
112. Rochette-Egly C., Oulad-Abdelghani M., Staub A., Pfister V., Scheuer I., Chambon P., Gaub M.P. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. 9:1995;860-871.
113. Rochette-Egly C., Adam S., Rossignol M., Egly J.M., Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell. 90:1997;97-107.
114. Ross S.A., McCaffery P.J., Drager U.C., De Luca L.M. Retinoids in embryonal development. Physiol. Rev. 80:2000;1021-1054.
115. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Ann. Rev. Biochem. 70:2001;81-120.
116. Rowan B.G., Garrison N., Weigel N.L., O'Malley B.W. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol. Cell. Biol. 20:2000;8720-8730.
117. Rowan B.G., Weigel N.L., O'Malley B.W. Phosphorylation of steroid receptor coactivator: 1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J. Biol. Chem. 275:2000;4475-4483.
118. Roy B., Taneja R., Chambon P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15:1995;6481-6487.
119. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science. 293:2001;1651-1653.
120. Sandrock B., Egly J.M. A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH. J. Biol. Chem. 276:2001;35328-35333.
121. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-E136.
122. Si J., Collins S.J. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood. 100:2002;4401-4409.
123. Smith W.C., Nakshatri H., Leroy P., Rees J., Chambon P. A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. EMBO J. 10:1991;2223-2230.
124. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45.
125. Tanaka T., Rodriguez de la Concepcion M.L., De Luca L.M. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem. Pharmacol. 61:2001;1347-1355.
126. Taneja R., Rochette-Egly C., Plassat J.L., Penna L., Gaub M.P., Chambon P. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J. 16:1997;6452-6465.
127. Tansey W.P. Transcriptional activation: risky business. Genes Dev. 15:2001;1045-1050.
128. Tari A.M., Lim S.J., Hung M.C., Esteva F.J., Lopez-Berestein G. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene. 21:2002;5224-5232.
129. Vignali M., Hassan A.H., Neely K.E., Workman J.L. ATP-dependent chromatin-remodeling complexes. Mol. Cell. Biol. 20:2000;1899-1910.
130. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:2001;13505-13508.
131. vom Baur E., Zechel C., Heery D., Heine M.J., Garnier J.M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:1996;110-124.
132. Wallace A.D., Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276:2001;42714-42721.
133. Wang J., Barsky L.W., Shum C.H., Jong A., Weinberg K.I., Collins S.J., Triche T.J., Wu L. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J. Biol. Chem. 277:2002;43369-43376.
134. Weeda G., Rossignol M., Fraser R.A., Winkler G.S., Vermeulen W., van't Veer L.J., Ma L., Hoeijmakers J.H., Egly J.M. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor. Nucleic Acids Res. 25:1997;2274-2283.
135. Willy P.J., Mangelsdorf D.J. Nuclear orphan receptors:the search for novel ligands and signaling pathways. O'Malley B.W. Hormone and Signaling. 1999;307-358 Academic Press, San Diego.
136. Woychik N.A., Hampsey M. The RNA polymerase II machinery: structure illuminates function. Cell. 108:2002;453-463.
137. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. (see comments) Nat. Struct. Biol. 3:1996;87-94. (published erratum appears in Nat Struct Biol 1996 Feb; 3(2):206).
138. Xiao J.H., Ghosn C., Hinchman C., Forbes C., Wang J., Snider N., Cordrey A., Zhao Y., Chandraratna R.A. APC-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J. Biol. Chem. 278:2003;29954-29962.
139. Yan F., Gao X., Lonard D.M., Nawaz Z. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators. Mol. Endocrinol. 17:2003;1315-1331.
140. Zechel C., Shen X.Q., Chambon P., Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J. 13:1994;1414-1424.
141. Zechel C., Shen X.Q., Chen J.Y., Chen Z.P., Chambon P., Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13:1994;1425-1433.
142. Zhang Y., Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15:2001;2343-2360.
143. Zhou X.F., Shen X.Q., Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol. Endocrinol. 13:1999;276-285.
144. Zhu J., Gianni M., Kopf E., Honore N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., de Thé H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor a (RARa) and oncogenic RARa fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14807-14812.